US FTC takes action against GoodRx for sharing sensitive health info 07-Feb-2023 By Ben Hargreaves The commission took enforcement action for the first time under its Health Breach Notification Rule against GoodRx.
BMS has to divest blockbuster to complete Celgene acquisition 25-Jun-2019 By Ben Hargreaves The share price of BMS sank by over 7% after it stated that it would need to divest Celgene’s Otezla, a blockbuster treatment for psoriasis and psoriatic arthritis.